February 26, 2021
By Matt Hoffman
Data from a pair of posters suggest that cognition, fatigue, and depression all impact social activity limitations in people with MS, rather than walking impairment alone.
February 26, 2021
By NeurologyLive Staff
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending February 26, 2021.
February 26, 2021
By Victoria Johnson
Researchers investigated the test, which is normally used to differentiate people with MS from healthy controls, in a population of those with multiple sclerosis.
February 26, 2021
By Victoria Johnson
The trial of anakinra is underway, while the trial for tolebrutinib is undergoing regulatory review.
February 25, 2021
By Marco Meglio
The authors concluded that this approach may be applied in fatigue management treatment protocols, without increasing symptoms, in patients with multiple sclerosis.